LSI is Officially Heading to Singapore — Register for LSI Asia '25 Today

SIRAKOSS

Third-generation, fully synthetic bone graft substitute that is not pharmacological in nature and does not contain any human or animal derived compone....

Get a Demo and See the Full Profile

Get a demo today to see profiles of SIRAKOSS plus 6116 other startups.

Learn More About SIRAKOSS

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

Competing Startups

More